Global Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2026-2032
The global Sialylated Human Milk Oligosaccharides (HMO) market size is expected to reach $ 441 million by 2032, rising at a market growth of 16.1% CAGR during the forecast period (2026-2032).
In 2025, global Sialylated Human Milk Oligosaccharides (HMO) production reached approximately 802 tons, with an average global market price of around US$191 per kilogram. Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3'-Sialyllactose (3'-SL) and 6?-sialyllactose (6'-SL) are two simplest sialylated HMOs.
The global market for sialylated Human Milk Oligosaccharides (HMOs) is shifting from basic supplementation toward specialized functional nutrition. Synthetic biology breakthroughs have established microbial fermentation as the dominant production route, with domestic pioneers achieving commercial production of synthetic HMO products and breaking previous import dependency. Kyowa Hakko Bio completed an HMO production facility in Thailand in 2022 and began commercial production there; in 2023 it received FDA no-question letters covering 3'-SL and 6'-SL for non-exempt infant formula and conventional foods, and in 2024 its 3'-SL and 6'-SL were already within the EU novel-food authorization framework, indicating that major-market access is opening. As a result, competition is shifting from simple capacity expansion to quality standards, regulatory capability, and supply reliability. Future growth will mainly come from infant nutrition and premium nutrition formulations that seek ingredients closer to human milk, together with broader approved food categories and geographies. At the same time, high purity requirements, complex processing, long approval cycles, cost pressure, and a still-concentrated supply base remain the main constraints. Overall, this segment is likely to expand through high-value, regulation-led, stepwise commercialization rather than rapid mass adoption.
This report studies the global Sialylated Human Milk Oligosaccharides (HMO) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sialylated Human Milk Oligosaccharides (HMO) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sialylated Human Milk Oligosaccharides (HMO) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sialylated Human Milk Oligosaccharides (HMO) total production and demand, 2021-2032, (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) total production value, 2021-2032, (USD Million)
Global Sialylated Human Milk Oligosaccharides (HMO) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Sialylated Human Milk Oligosaccharides (HMO) consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Sialylated Human Milk Oligosaccharides (HMO) domestic production, consumption, key domestic manufacturers and share
Global Sialylated Human Milk Oligosaccharides (HMO) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Sialylated Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novonesis, Inbiose, DSM (Glycom A/S), Kyowa Hakko Bio, GeneChem Inc., Elicityl, Zhuhai Langjian Biotechnology, Shanghai HuicH Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sialylated Human Milk Oligosaccharides (HMO) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sialylated Human Milk Oligosaccharides (HMO) Market, By Region:
1. How big is the global Sialylated Human Milk Oligosaccharides (HMO) market?
2. What is the demand of the global Sialylated Human Milk Oligosaccharides (HMO) market?
3. What is the year over year growth of the global Sialylated Human Milk Oligosaccharides (HMO) market?
4. What is the production and production value of the global Sialylated Human Milk Oligosaccharides (HMO) market?
5. Who are the key producers in the global Sialylated Human Milk Oligosaccharides (HMO) market?
6. What are the growth factors driving the market demand?
In 2025, global Sialylated Human Milk Oligosaccharides (HMO) production reached approximately 802 tons, with an average global market price of around US$191 per kilogram. Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3'-Sialyllactose (3'-SL) and 6?-sialyllactose (6'-SL) are two simplest sialylated HMOs.
The global market for sialylated Human Milk Oligosaccharides (HMOs) is shifting from basic supplementation toward specialized functional nutrition. Synthetic biology breakthroughs have established microbial fermentation as the dominant production route, with domestic pioneers achieving commercial production of synthetic HMO products and breaking previous import dependency. Kyowa Hakko Bio completed an HMO production facility in Thailand in 2022 and began commercial production there; in 2023 it received FDA no-question letters covering 3'-SL and 6'-SL for non-exempt infant formula and conventional foods, and in 2024 its 3'-SL and 6'-SL were already within the EU novel-food authorization framework, indicating that major-market access is opening. As a result, competition is shifting from simple capacity expansion to quality standards, regulatory capability, and supply reliability. Future growth will mainly come from infant nutrition and premium nutrition formulations that seek ingredients closer to human milk, together with broader approved food categories and geographies. At the same time, high purity requirements, complex processing, long approval cycles, cost pressure, and a still-concentrated supply base remain the main constraints. Overall, this segment is likely to expand through high-value, regulation-led, stepwise commercialization rather than rapid mass adoption.
This report studies the global Sialylated Human Milk Oligosaccharides (HMO) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sialylated Human Milk Oligosaccharides (HMO) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sialylated Human Milk Oligosaccharides (HMO) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sialylated Human Milk Oligosaccharides (HMO) total production and demand, 2021-2032, (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) total production value, 2021-2032, (USD Million)
Global Sialylated Human Milk Oligosaccharides (HMO) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Sialylated Human Milk Oligosaccharides (HMO) consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Sialylated Human Milk Oligosaccharides (HMO) domestic production, consumption, key domestic manufacturers and share
Global Sialylated Human Milk Oligosaccharides (HMO) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Sialylated Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novonesis, Inbiose, DSM (Glycom A/S), Kyowa Hakko Bio, GeneChem Inc., Elicityl, Zhuhai Langjian Biotechnology, Shanghai HuicH Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sialylated Human Milk Oligosaccharides (HMO) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Sialylated Human Milk Oligosaccharides (HMO) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 3'-Sialyllactose (3'-SL)
- 6'-Sialyllactose (6'-SL)
- Microbial Fermentation
- Enzymatic Synthesis
- Food Grade
- Research Grade
- Infant Formula
- Food
- Others
- Novonesis
- Inbiose
- DSM (Glycom A/S)
- Kyowa Hakko Bio
- GeneChem Inc.
- Elicityl
- Zhuhai Langjian Biotechnology
- Shanghai HuicH Biotech
1. How big is the global Sialylated Human Milk Oligosaccharides (HMO) market?
2. What is the demand of the global Sialylated Human Milk Oligosaccharides (HMO) market?
3. What is the year over year growth of the global Sialylated Human Milk Oligosaccharides (HMO) market?
4. What is the production and production value of the global Sialylated Human Milk Oligosaccharides (HMO) market?
5. Who are the key producers in the global Sialylated Human Milk Oligosaccharides (HMO) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Sialylated Human Milk Oligosaccharides (HMO) Introduction
1.2 World Sialylated Human Milk Oligosaccharides (HMO) Supply & Forecast
1.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021 & 2025 & 2032)
1.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.2.3 World Sialylated Human Milk Oligosaccharides (HMO) Pricing Trends (2021-2032)
1.3 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (Based on Production Site)
1.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021-2032)
1.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2021-2032)
1.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2021-2032)
1.3.4 North America Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.6 China Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.7 Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
2 DEMAND SUMMARY
2.1 World Sialylated Human Milk Oligosaccharides (HMO) Demand (2021-2032)
2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region
2.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2021-2026)
2.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2027-2032)
2.3 United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.4 China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.6 Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.7 South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.8 ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.9 India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2021-2026)
3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2021-2026)
3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2021-2026)
3.4 Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) in 2025
3.5.3 Global Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) in 2025
3.6 Sialylated Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
3.6.1 Sialylated Human Milk Oligosaccharides (HMO) Market: Region Footprint
3.6.2 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
3.6.3 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison
4.1.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison
4.2.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison
4.3.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
4.5 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share
4.5.1 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.5.3 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
4.6 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 3'-Sialyllactose (3'-SL)
5.2.2 6'-Sialyllactose (6'-SL)
5.3 Market Segment by Type
5.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2021-2032)
5.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2021-2032)
5.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PROCESS
6.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Process
6.2.1 Microbial Fermentation
6.2.2 Enzymatic Synthesis
6.3 Market Segment by Process
6.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2021-2032)
6.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2021-2032)
6.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2032)
7 MARKET ANALYSIS BY GRADE
7.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Grade: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Grade
7.2.1 Food Grade
7.2.2 Research Grade
7.3 Market Segment by Grade
7.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2021-2032)
7.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2021-2032)
7.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Infant Formula
8.2.2 Food
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2021-2032)
8.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2021-2032)
8.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novonesis
9.1.1 Novonesis Details
9.1.2 Novonesis Major Business
9.1.3 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.1.4 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novonesis Recent Developments/Updates
9.1.6 Novonesis Competitive Strengths & Weaknesses
9.2 Inbiose
9.2.1 Inbiose Details
9.2.2 Inbiose Major Business
9.2.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.2.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Inbiose Recent Developments/Updates
9.2.6 Inbiose Competitive Strengths & Weaknesses
9.3 DSM (Glycom A/S)
9.3.1 DSM (Glycom A/S) Details
9.3.2 DSM (Glycom A/S) Major Business
9.3.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.3.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 DSM (Glycom A/S) Recent Developments/Updates
9.3.6 DSM (Glycom A/S) Competitive Strengths & Weaknesses
9.4 Kyowa Hakko Bio
9.4.1 Kyowa Hakko Bio Details
9.4.2 Kyowa Hakko Bio Major Business
9.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Kyowa Hakko Bio Recent Developments/Updates
9.4.6 Kyowa Hakko Bio Competitive Strengths & Weaknesses
9.5 GeneChem Inc.
9.5.1 GeneChem Inc. Details
9.5.2 GeneChem Inc. Major Business
9.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 GeneChem Inc. Recent Developments/Updates
9.5.6 GeneChem Inc. Competitive Strengths & Weaknesses
9.6 Elicityl
9.6.1 Elicityl Details
9.6.2 Elicityl Major Business
9.6.3 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.6.4 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Elicityl Recent Developments/Updates
9.6.6 Elicityl Competitive Strengths & Weaknesses
9.7 Zhuhai Langjian Biotechnology
9.7.1 Zhuhai Langjian Biotechnology Details
9.7.2 Zhuhai Langjian Biotechnology Major Business
9.7.3 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.7.4 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zhuhai Langjian Biotechnology Recent Developments/Updates
9.7.6 Zhuhai Langjian Biotechnology Competitive Strengths & Weaknesses
9.8 Shanghai HuicH Biotech
9.8.1 Shanghai HuicH Biotech Details
9.8.2 Shanghai HuicH Biotech Major Business
9.8.3 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.8.4 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Shanghai HuicH Biotech Recent Developments/Updates
9.8.6 Shanghai HuicH Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
10.2 Sialylated Human Milk Oligosaccharides (HMO) Upstream Analysis
10.2.1 Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
10.2.2 Main Manufacturers of Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sialylated Human Milk Oligosaccharides (HMO) Production Mode
10.6 Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
10.7 Sialylated Human Milk Oligosaccharides (HMO) Industry Sales Model and Sales Channels
10.7.1 Sialylated Human Milk Oligosaccharides (HMO) Sales Model
10.7.2 Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Sialylated Human Milk Oligosaccharides (HMO) Introduction
1.2 World Sialylated Human Milk Oligosaccharides (HMO) Supply & Forecast
1.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021 & 2025 & 2032)
1.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.2.3 World Sialylated Human Milk Oligosaccharides (HMO) Pricing Trends (2021-2032)
1.3 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (Based on Production Site)
1.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021-2032)
1.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2021-2032)
1.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2021-2032)
1.3.4 North America Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.6 China Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.3.7 Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
2 DEMAND SUMMARY
2.1 World Sialylated Human Milk Oligosaccharides (HMO) Demand (2021-2032)
2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region
2.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2021-2026)
2.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2027-2032)
2.3 United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.4 China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.6 Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.7 South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.8 ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
2.9 India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2021-2026)
3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2021-2026)
3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2021-2026)
3.4 Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) in 2025
3.5.3 Global Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) in 2025
3.6 Sialylated Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
3.6.1 Sialylated Human Milk Oligosaccharides (HMO) Market: Region Footprint
3.6.2 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
3.6.3 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison
4.1.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison
4.2.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison
4.3.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
4.5 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share
4.5.1 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.5.3 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
4.6 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 3'-Sialyllactose (3'-SL)
5.2.2 6'-Sialyllactose (6'-SL)
5.3 Market Segment by Type
5.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2021-2032)
5.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2021-2032)
5.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PROCESS
6.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Process
6.2.1 Microbial Fermentation
6.2.2 Enzymatic Synthesis
6.3 Market Segment by Process
6.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2021-2032)
6.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2021-2032)
6.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2032)
7 MARKET ANALYSIS BY GRADE
7.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Grade: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Grade
7.2.1 Food Grade
7.2.2 Research Grade
7.3 Market Segment by Grade
7.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2021-2032)
7.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2021-2032)
7.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Infant Formula
8.2.2 Food
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2021-2032)
8.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2021-2032)
8.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Novonesis
9.1.1 Novonesis Details
9.1.2 Novonesis Major Business
9.1.3 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.1.4 Novonesis Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Novonesis Recent Developments/Updates
9.1.6 Novonesis Competitive Strengths & Weaknesses
9.2 Inbiose
9.2.1 Inbiose Details
9.2.2 Inbiose Major Business
9.2.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.2.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Inbiose Recent Developments/Updates
9.2.6 Inbiose Competitive Strengths & Weaknesses
9.3 DSM (Glycom A/S)
9.3.1 DSM (Glycom A/S) Details
9.3.2 DSM (Glycom A/S) Major Business
9.3.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.3.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 DSM (Glycom A/S) Recent Developments/Updates
9.3.6 DSM (Glycom A/S) Competitive Strengths & Weaknesses
9.4 Kyowa Hakko Bio
9.4.1 Kyowa Hakko Bio Details
9.4.2 Kyowa Hakko Bio Major Business
9.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Kyowa Hakko Bio Recent Developments/Updates
9.4.6 Kyowa Hakko Bio Competitive Strengths & Weaknesses
9.5 GeneChem Inc.
9.5.1 GeneChem Inc. Details
9.5.2 GeneChem Inc. Major Business
9.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 GeneChem Inc. Recent Developments/Updates
9.5.6 GeneChem Inc. Competitive Strengths & Weaknesses
9.6 Elicityl
9.6.1 Elicityl Details
9.6.2 Elicityl Major Business
9.6.3 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.6.4 Elicityl Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Elicityl Recent Developments/Updates
9.6.6 Elicityl Competitive Strengths & Weaknesses
9.7 Zhuhai Langjian Biotechnology
9.7.1 Zhuhai Langjian Biotechnology Details
9.7.2 Zhuhai Langjian Biotechnology Major Business
9.7.3 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.7.4 Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Zhuhai Langjian Biotechnology Recent Developments/Updates
9.7.6 Zhuhai Langjian Biotechnology Competitive Strengths & Weaknesses
9.8 Shanghai HuicH Biotech
9.8.1 Shanghai HuicH Biotech Details
9.8.2 Shanghai HuicH Biotech Major Business
9.8.3 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product and Services
9.8.4 Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Shanghai HuicH Biotech Recent Developments/Updates
9.8.6 Shanghai HuicH Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
10.2 Sialylated Human Milk Oligosaccharides (HMO) Upstream Analysis
10.2.1 Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
10.2.2 Main Manufacturers of Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Sialylated Human Milk Oligosaccharides (HMO) Production Mode
10.6 Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
10.7 Sialylated Human Milk Oligosaccharides (HMO) Industry Sales Model and Sales Channels
10.7.1 Sialylated Human Milk Oligosaccharides (HMO) Sales Model
10.7.2 Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2021-2026)
Table 5. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2027-2032)
Table 6. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2021-2026) & (Tons)
Table 7. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2027-2032) & (Tons)
Table 8. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2021-2026)
Table 9. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2027-2032)
Table 10. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2021-2026) & (US$/Kg)
Table 11. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2027-2032) & (US$/Kg)
Table 12. Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
Table 13. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2021-2026) & (Tons)
Table 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2025
Table 18. World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2025
Table 20. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2021-2026) & (US$/Kg)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
Table 22. World Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sialylated Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
Table 24. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
Table 25. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
Table 26. Sialylated Human Milk Oligosaccharides (HMO) Competitive Factors
Table 27. Sialylated Human Milk Oligosaccharides (HMO) New Entrant and Capacity Expansion Plans
Table 28. Sialylated Human Milk Oligosaccharides (HMO) Mergers & Acquisitions Activity
Table 29. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 37. China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 42. Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 47. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2021-2026) & (Tons)
Table 49. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2027-2032) & (Tons)
Table 50. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2026) & (US$/Kg)
Table 53. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2027-2032) & (US$/Kg)
Table 54. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process, (USD Million), 2021 & 2025 & 2032
Table 55. World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2021-2026) & (Tons)
Table 56. World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2027-2032) & (Tons)
Table 57. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2021-2026) & (USD Million)
Table 58. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2027-2032) & (USD Million)
Table 59. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2026) & (US$/Kg)
Table 60. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2027-2032) & (US$/Kg)
Table 61. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Table 62. World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2021-2026) & (Tons)
Table 63. World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2027-2032) & (Tons)
Table 64. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2021-2026) & (USD Million)
Table 65. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2027-2032) & (USD Million)
Table 66. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2026) & (US$/Kg)
Table 67. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2027-2032) & (US$/Kg)
Table 68. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2021-2026) & (Tons)
Table 70. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2027-2032) & (Tons)
Table 71. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2026) & (US$/Kg)
Table 74. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2027-2032) & (US$/Kg)
Table 75. Novonesis Basic Information, Manufacturing Base and Competitors
Table 76. Novonesis Major Business
Table 77. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 78. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novonesis Recent Developments/Updates
Table 80. Novonesis Competitive Strengths & Weaknesses
Table 81. Inbiose Basic Information, Manufacturing Base and Competitors
Table 82. Inbiose Major Business
Table 83. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 84. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Inbiose Recent Developments/Updates
Table 86. Inbiose Competitive Strengths & Weaknesses
Table 87. DSM (Glycom A/S) Basic Information, Manufacturing Base and Competitors
Table 88. DSM (Glycom A/S) Major Business
Table 89. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 90. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. DSM (Glycom A/S) Recent Developments/Updates
Table 92. DSM (Glycom A/S) Competitive Strengths & Weaknesses
Table 93. Kyowa Hakko Bio Basic Information, Manufacturing Base and Competitors
Table 94. Kyowa Hakko Bio Major Business
Table 95. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 96. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Kyowa Hakko Bio Recent Developments/Updates
Table 98. Kyowa Hakko Bio Competitive Strengths & Weaknesses
Table 99. GeneChem Inc. Basic Information, Manufacturing Base and Competitors
Table 100. GeneChem Inc. Major Business
Table 101. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 102. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. GeneChem Inc. Recent Developments/Updates
Table 104. GeneChem Inc. Competitive Strengths & Weaknesses
Table 105. Elicityl Basic Information, Manufacturing Base and Competitors
Table 106. Elicityl Major Business
Table 107. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 108. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Elicityl Recent Developments/Updates
Table 110. Elicityl Competitive Strengths & Weaknesses
Table 111. Zhuhai Langjian Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Zhuhai Langjian Biotechnology Major Business
Table 113. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 114. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zhuhai Langjian Biotechnology Recent Developments/Updates
Table 116. Zhuhai Langjian Biotechnology Competitive Strengths & Weaknesses
Table 117. Shanghai HuicH Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Shanghai HuicH Biotech Major Business
Table 119. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 120. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Shanghai HuicH Biotech Recent Developments/Updates
Table 122. Shanghai HuicH Biotech Competitive Strengths & Weaknesses
Table 123. Global Key Players of Sialylated Human Milk Oligosaccharides (HMO) Upstream (Raw Materials)
Table 124. Global Sialylated Human Milk Oligosaccharides (HMO) Typical Customers
Table 125. Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
Table 1. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2021-2026)
Table 5. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2027-2032)
Table 6. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2021-2026) & (Tons)
Table 7. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2027-2032) & (Tons)
Table 8. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2021-2026)
Table 9. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2027-2032)
Table 10. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2021-2026) & (US$/Kg)
Table 11. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2027-2032) & (US$/Kg)
Table 12. Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
Table 13. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2021-2026) & (Tons)
Table 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2025
Table 18. World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2025
Table 20. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2021-2026) & (US$/Kg)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
Table 22. World Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Sialylated Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
Table 24. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
Table 25. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
Table 26. Sialylated Human Milk Oligosaccharides (HMO) Competitive Factors
Table 27. Sialylated Human Milk Oligosaccharides (HMO) New Entrant and Capacity Expansion Plans
Table 28. Sialylated Human Milk Oligosaccharides (HMO) Mergers & Acquisitions Activity
Table 29. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 37. China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 42. Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2021-2026)
Table 47. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2021-2026) & (Tons)
Table 49. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2027-2032) & (Tons)
Table 50. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2026) & (US$/Kg)
Table 53. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2027-2032) & (US$/Kg)
Table 54. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process, (USD Million), 2021 & 2025 & 2032
Table 55. World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2021-2026) & (Tons)
Table 56. World Sialylated Human Milk Oligosaccharides (HMO) Production by Process (2027-2032) & (Tons)
Table 57. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2021-2026) & (USD Million)
Table 58. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process (2027-2032) & (USD Million)
Table 59. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2026) & (US$/Kg)
Table 60. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2027-2032) & (US$/Kg)
Table 61. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Table 62. World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2021-2026) & (Tons)
Table 63. World Sialylated Human Milk Oligosaccharides (HMO) Production by Grade (2027-2032) & (Tons)
Table 64. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2021-2026) & (USD Million)
Table 65. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade (2027-2032) & (USD Million)
Table 66. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2026) & (US$/Kg)
Table 67. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2027-2032) & (US$/Kg)
Table 68. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2021-2026) & (Tons)
Table 70. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2027-2032) & (Tons)
Table 71. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2026) & (US$/Kg)
Table 74. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2027-2032) & (US$/Kg)
Table 75. Novonesis Basic Information, Manufacturing Base and Competitors
Table 76. Novonesis Major Business
Table 77. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 78. Novonesis Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Novonesis Recent Developments/Updates
Table 80. Novonesis Competitive Strengths & Weaknesses
Table 81. Inbiose Basic Information, Manufacturing Base and Competitors
Table 82. Inbiose Major Business
Table 83. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 84. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Inbiose Recent Developments/Updates
Table 86. Inbiose Competitive Strengths & Weaknesses
Table 87. DSM (Glycom A/S) Basic Information, Manufacturing Base and Competitors
Table 88. DSM (Glycom A/S) Major Business
Table 89. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 90. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. DSM (Glycom A/S) Recent Developments/Updates
Table 92. DSM (Glycom A/S) Competitive Strengths & Weaknesses
Table 93. Kyowa Hakko Bio Basic Information, Manufacturing Base and Competitors
Table 94. Kyowa Hakko Bio Major Business
Table 95. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 96. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Kyowa Hakko Bio Recent Developments/Updates
Table 98. Kyowa Hakko Bio Competitive Strengths & Weaknesses
Table 99. GeneChem Inc. Basic Information, Manufacturing Base and Competitors
Table 100. GeneChem Inc. Major Business
Table 101. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 102. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. GeneChem Inc. Recent Developments/Updates
Table 104. GeneChem Inc. Competitive Strengths & Weaknesses
Table 105. Elicityl Basic Information, Manufacturing Base and Competitors
Table 106. Elicityl Major Business
Table 107. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 108. Elicityl Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Elicityl Recent Developments/Updates
Table 110. Elicityl Competitive Strengths & Weaknesses
Table 111. Zhuhai Langjian Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Zhuhai Langjian Biotechnology Major Business
Table 113. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 114. Zhuhai Langjian Biotechnology Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Zhuhai Langjian Biotechnology Recent Developments/Updates
Table 116. Zhuhai Langjian Biotechnology Competitive Strengths & Weaknesses
Table 117. Shanghai HuicH Biotech Basic Information, Manufacturing Base and Competitors
Table 118. Shanghai HuicH Biotech Major Business
Table 119. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 120. Shanghai HuicH Biotech Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Shanghai HuicH Biotech Recent Developments/Updates
Table 122. Shanghai HuicH Biotech Competitive Strengths & Weaknesses
Table 123. Global Key Players of Sialylated Human Milk Oligosaccharides (HMO) Upstream (Raw Materials)
Table 124. Global Sialylated Human Milk Oligosaccharides (HMO) Typical Customers
Table 125. Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
LIST OF FIGURES
Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Picture
Figure 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 5. World Sialylated Human Milk Oligosaccharides (HMO) Average Price (2021-2032) & (US$/Kg)
Figure 6. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2021-2032)
Figure 7. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2021-2032)
Figure 8. North America Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 9. Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 10. China Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 11. Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 12. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share by Region (2021-2032)
Figure 16. United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 17. China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 18. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 19. Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 20. South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 22. India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2025
Figure 26. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 30. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 32. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type in 2025
Figure 34. 3'-Sialyllactose (3'-SL)
Figure 35. 6'-Sialyllactose (6'-SL)
Figure 36. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Type (2021-2032)
Figure 37. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type (2021-2032)
Figure 38. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2032) & (US$/Kg)
Figure 39. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process, (USD Million), 2021 & 2025 & 2032
Figure 40. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Process in 2025
Figure 41. Microbial Fermentation
Figure 42. Enzymatic Synthesis
Figure 43. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Process (2021-2032)
Figure 44. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Process (2021-2032)
Figure 45. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2032) & (US$/Kg)
Figure 46. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Figure 47. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Grade in 2025
Figure 48. Food Grade
Figure 49. Research Grade
Figure 50. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Grade (2021-2032)
Figure 51. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Grade (2021-2032)
Figure 52. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2032) & (US$/Kg)
Figure 53. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application in 2025
Figure 55. Infant Formula
Figure 56. Food
Figure 57. Others
Figure 58. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Application (2021-2032)
Figure 59. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application (2021-2032)
Figure 60. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2032) & (US$/Kg)
Figure 61. Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
Figure 62. Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
Figure 63. Sialylated Human Milk Oligosaccharides (HMO) Sales Model
Figure 64. Sialylated Human Milk Oligosaccharides (HMO) Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Picture
Figure 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 5. World Sialylated Human Milk Oligosaccharides (HMO) Average Price (2021-2032) & (US$/Kg)
Figure 6. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2021-2032)
Figure 7. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2021-2032)
Figure 8. North America Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 9. Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 10. China Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 11. Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2021-2032) & (Tons)
Figure 12. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share by Region (2021-2032)
Figure 16. United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 17. China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 18. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 19. Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 20. South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 22. India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2025
Figure 26. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 30. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2025
Figure 32. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type in 2025
Figure 34. 3'-Sialyllactose (3'-SL)
Figure 35. 6'-Sialyllactose (6'-SL)
Figure 36. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Type (2021-2032)
Figure 37. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type (2021-2032)
Figure 38. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2021-2032) & (US$/Kg)
Figure 39. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Process, (USD Million), 2021 & 2025 & 2032
Figure 40. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Process in 2025
Figure 41. Microbial Fermentation
Figure 42. Enzymatic Synthesis
Figure 43. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Process (2021-2032)
Figure 44. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Process (2021-2032)
Figure 45. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Process (2021-2032) & (US$/Kg)
Figure 46. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Grade, (USD Million), 2021 & 2025 & 2032
Figure 47. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Grade in 2025
Figure 48. Food Grade
Figure 49. Research Grade
Figure 50. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Grade (2021-2032)
Figure 51. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Grade (2021-2032)
Figure 52. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Grade (2021-2032) & (US$/Kg)
Figure 53. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application in 2025
Figure 55. Infant Formula
Figure 56. Food
Figure 57. Others
Figure 58. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Application (2021-2032)
Figure 59. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application (2021-2032)
Figure 60. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2021-2032) & (US$/Kg)
Figure 61. Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
Figure 62. Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
Figure 63. Sialylated Human Milk Oligosaccharides (HMO) Sales Model
Figure 64. Sialylated Human Milk Oligosaccharides (HMO) Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
